These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26857460)

  • 41. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel small molecule inhibitors of the OLIG2 transcription factor: promising new therapeutics for glioblastoma.
    Alton G; Kesari S
    Future Oncol; 2016; 12(8):1001-4. PubMed ID: 26867754
    [No Abstract]   [Full Text] [Related]  

  • 43. Glioblastoma: Defining Tumor Niches.
    Hambardzumyan D; Bergers G
    Trends Cancer; 2015 Dec; 1(4):252-265. PubMed ID: 27088132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
    Wang D; Berglund A; Kenchappa RS; Forsyth PA; Mulé JJ; Etame AB
    Sci Rep; 2016 Feb; 6():21710. PubMed ID: 26888114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 Mutation.
    Liu A; Hou C; Chen H; Zong X; Zong P
    Front Oncol; 2016; 6():16. PubMed ID: 26858939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The landscape of the mesenchymal signature in brain tumours.
    Behnan J; Finocchiaro G; Hanna G
    Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma.
    Formato A; Salbini M; Orecchini E; Pellegrini M; Buccarelli M; Vitiani LR; Giannetti S; Pallini R; D'Alessandris QG; Lauretti L; Martini M; De Falco V; Levi A; Falchetti ML; Mongiardi MP
    Cancer Med; 2024 Oct; 13(19):e70279. PubMed ID: 39377544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.
    Xu C; Hou P; Li X; Xiao M; Zhang Z; Li Z; Xu J; Liu G; Tan Y; Fang C
    Cancer Biol Med; 2024 May; 21(5):363-81. PubMed ID: 38712813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes Induced by P2X7 Receptor Stimulation of Human Glioblastoma Stem Cells in the Proteome of Extracellular Vesicles Isolated from Their Secretome.
    Di Giuseppe F; Ricci-Vitiani L; Pallini R; Di Pietro R; Di Iorio P; Ascani G; Ciccarelli R; Angelucci S
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
    Nassani R; Bokhari Y; Alrfaei BM
    PLoS One; 2023; 18(11):e0287448. PubMed ID: 37972206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repurposing Clemastine to Target Glioblastoma Cell Stemness.
    Sun MA; Yang R; Liu H; Wang W; Song X; Hu B; Reynolds N; Roso K; Chen LH; Greer PK; Keir ST; McLendon RE; Cheng SY; Bigner DD; Ashley DM; Pirozzi CJ; He Y
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Machine learning based combination of multi-omics data for subgroup identification in non-small cell lung cancer.
    Khadirnaikar S; Shukla S; Prasanna SRM
    Sci Rep; 2023 Mar; 13(1):4636. PubMed ID: 36944673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme.
    Cencioni C; Scagnoli F; Spallotta F; Nasi S; Illi B
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like Cells.
    Dini V; Esposito G; Sacconi A; D'Andrea M; Tabocchini MA; Anello P; Ricci-Vitiani L; Buccarelli M; Pallini R; Strigari L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research.
    Ahmed M; Semreen AM; El-Huneidi W; Bustanji Y; Abu-Gharbieh E; Alqudah MAY; Alhusban A; Shara M; Abuhelwa AY; Soares NC; Semreen MH; Alzoubi KH
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of Glioblastoma Cells Response to Regorafenib.
    Mongiardi MP; Buccarelli M; Formato A; Orecchini E; Salbini M; Ricci V; Orsini T; Putti S; Chiesa S; Ricci-Vitiani L; D'Alessandris QG; Pallini R; Levi A; Falchetti ML
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.
    Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
    Mol Oncol; 2023 Feb; 17(2):238-260. PubMed ID: 36495079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression.
    Di Bonaventura R; Martini M; Cenci T; Caccavella VM; Barresi V; Gessi M; Albanese A; Lauretti L; Pallini R; D'Alessandris QG; Olivi A
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical Treatments.
    Grande S; Palma A; Luciani AM; Anello P; Ricci-Vitiani L; Buccarelli M; D'Alessandris QG; Pallini R; Guidoni L; Viti V; Rosi A
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia.
    Proserpio C; Galardi S; Desimio MG; Michienzi A; Doria M; Minutolo A; Matteucci C; Ciafrè SA
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.